Original news and analysis on international IP policy
Kamil Idris, director general of the World Intellectual Property Organization, has acted to correct his age as it is recorded at WIPO after 20 years, setting off speculation that he stands to gain handsomely from the change. In addition, some…
Por William New y Tove Iren S. Gerhardsen El 30 de junio, después de dos semanas de reuniones e intensas consultas a lo largo del año, se dio fin a los debates encaminados a reforzar la perspectiva de desarrollo de…
Par William New et Tove Iren S. Gerhardsen Au terme de deux sessions d’une semaine et d’intenses consultations hors session, les discussions en faveur d’une meilleure intégration de la problématique du développement dans les travaux de l’Organisation mondiale de la…
The powerful Programme and Budget Committee (PBC) of the World Intellectual Property Organization this week appears to be in agreement with WIPO management on several critical and previously contentious endeavours. At the sparsely attended first day of the 11-13 July…
BRUSSELS – The European Commission today fined Microsoft €280.5 million ($356.35 million) for failing to comply with a 2004 Commission request to provide documents that would make it easier for other companies to develop products that would be interoperable with…
By Monika Ermert for Intellectual Property Watch Procedural questions could kill a proposed European Union directive aimed at fighting theft of products, patents and copyrights, after the Dutch Parliament raised jurisdictional objections last week. At issue is the planned EU…
The Intellectual Property Watch Monthly Reporter features unique summaries of events, the latest on who is coming and going at the UN, WTO, Geneva missions, industry and NGOs, plus briefs on reports and events from the IP community. For this…
By Monika Ermert for Intellectual Property Watch Should everybody who registers an Internet domain name be forced to publish his private address, email address and phone number on the Internet? A storm broke out over the question of the so-called…
A monopoly by a single pharmaceutical company on a new medicine for HIV/AIDS has limited access to the medicine to a select group of patients in developing countries, a non-profit group said today. The product is lopinavir/ritonavir (Kaletra) and is…
With eight recently confirmed cases of avian influenza, Indonesia is scrambling to build up its stockpile of medicines. The preferred product to fight bird flu in humans is not under patent in Indonesia, which raises questions as to why production…